The present invention relates to the use of extracts from Pelargonium
species or plant parts thereof, particularly from P. sidoides and P.
reniforme for the prophylaxis or treatment of disease-related behavioural
changes, the chronic or post-viral asthenia syndrome and/or
stress-induced chronic pathological conditions as well as pharmaceutical
preparations containing these extracts.